In spite of the actual pandemic situation Ambinter remains open.

2021-02-08 12:11:00 As the COVID-19 global health crisis has taken many companies to reinvent and reorganize their operations, we at Ambinter c/o Greenpharma have been working to keeping up the level of service and supplying the chemicals you need for your R&D projects After having declared national lockdown in several European Countries, new measures have been adopted in order to fight the current outbreak of coronavirus; currently a nightly curfew is in force in Metropolitan France and many other bio-security measures are being taken into practice in Europe; this making our operations more complex; nevertheless and despite the exceptional situation, our teams are working at from our laboratory in Orleans France and remotely while complying with the security instructions given by our governments. Therefore, we are doing our best to prepare and finalize orders for our customers. You may experience longer lead times and delays. Thank you for your understanding and thank you for choosing Ambinter for your R&D projects Our teams are here to help, please do not hesitate to contact us for any query, we will be glad to assist.

other news from Ambinter

...
2023-06-23 14:44:10

Ambinter supplied FLIPinB

more
...
2022-01-28 09:11:00

Application of an integrated cheminformatics-molecular docking approach for discovery for physicochemically similar analogs of fluoroquinolones as putative HCV inhibitors.

more
...
2022-01-28 09:11:00

Discovery of New non-steroidal selective glucocorticoid receptor agonists

more